Why the study?
Is systemic inflammation associated with the presence of fragmented QRS complexes in patients with acute coronary syndromes?
Is systemic inflammation associated with the presence of fragmented QRS complexes in patients with acute coronary syndromes?
In patients with acute coronary syndromes, the presence of fragmented QRS complexes on admission ECG is independently associated with higher levels of systemic inflammation (CRP) and greater extent of coronary artery disease.
fQRS may reflect inflammation in ACS; hypothesis-generating for added prognostic value beyond CRP.
Background and Objectives: QRS complex fragmentations are frequently seen on routine electrocardiograms with narrow or wide QRS complex. Fragmented QRS complex (fQRS) is associated with increased morbidity and mortality, sudden cardiac death and recurrent cardiovascular events. In this study, we aimed to interrogate the relationship of systemic inflammation with the presence of fQRS in patients with acute coronary syndromes (ACS). Subjects and Methods: Two-hundred and twenty eligible patients with ACS that underwent coronary angiography were enrolled consecutively in this study. Patients with significant organic valve disease and those with any QRS morphology that had a QRS duration 120 ms as well as patients with permanent pacemakers were excluded from this study. Results: Patients with fQRS were of a higher age (p=0.02), had increased C-reactive protein (CRP) levels (p<0.001), prolonged QRS time (p<0.001), extent of coronary artery disease (CAD) (p<0.001), creatine kinase-MB (CK-MB) levels (p=0.006) and Q wave on admission electrocardiography (p<0.001) in comparison to patients with non-fragmented QRS. When we performed multiple logistic regression analysis, fQRS was found to be related to increased CRP levels { odds ratio (OR): 1.2, 95% confidence interval (CI): 1.045-1.316, p=0.007 } , QRS duration (OR: 1.1, 95% CI: 1.033-1.098, p<0.001), extent of CAD (OR: 1.5, 95% CI: 1.023-2.144, p=0.037), Q wave (OR: 2.2, 95% CI: 1.084-4.598, p=0.03) and CK-MB levels (OR: 1.0, 95% CI: 1.001-1.037, p=0.04) independently.
No takes yet. Share an insight, caveat, or question.
Çetın et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: